Health & Medicine Sipuleucel T Presentation Anna Begelfer Ostrovski

1. Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate CancerEric…

Documents HL7 Version 3 Laboratory Result-based Adverse Event Assessment Message Specifications RCRIM...

Slide 1 Slide 2 HL7 Version 3 Laboratory Result-based Adverse Event Assessment Message Specifications RCRIM Technical Meeting September 18, 2007 Jennifer Neat Project Leader,…